Jilin Jian Yisheng Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 15.22%

Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has an Asset Resilience Ratio of 15.22% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Jilin Jian Yisheng Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥454.04 Million

≈ $66.44 Million USD Cash + Short-term Investments

Total Assets

CN¥2.98 Billion

≈ $436.60 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2024)

This chart shows how Jilin Jian Yisheng Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Jilin Jian Yisheng Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jilin Jian Yisheng Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jilin Jian Yisheng Pharmaceutical Co Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥454.04 Million	15.22%
Total Liquid Assets	CN¥454.04 Million	15.22%

Asset Resilience Insights

Good Liquidity Position: Jilin Jian Yisheng Pharmaceutical Co Ltd maintains a healthy 15.22% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Jilin Jian Yisheng Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jilin Jian Yisheng Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Argen-X F:1AE	Biotechnology	25.67%
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	Biotechnology	0.21%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	35.96%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.48%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	70.49%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%

Annual Asset Resilience Ratio for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual Asset Resilience Ratio data for Jilin Jian Yisheng Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	15.47%	CN¥459.67 Million ≈ $67.26 Million	CN¥2.97 Billion ≈ $434.70 Million	+12.09pp
2023-12-31	3.38%	CN¥102.98 Million ≈ $15.07 Million	CN¥3.05 Billion ≈ $445.83 Million	+1.36pp
2022-12-31	2.02%	CN¥59.84 Million ≈ $8.76 Million	CN¥2.97 Billion ≈ $434.11 Million	-0.43pp
2021-12-31	2.45%	CN¥70.16 Million ≈ $10.27 Million	CN¥2.86 Billion ≈ $419.15 Million	+2.30pp
2017-12-31	0.15%	CN¥4.00 Million ≈ $585.33K	CN¥2.65 Billion ≈ $388.29 Million	-1.10pp
2015-12-31	1.25%	CN¥33.00 Million ≈ $4.83 Million	CN¥2.63 Billion ≈ $385.40 Million	-2.04pp
2014-12-31	3.29%	CN¥82.00 Million ≈ $12.00 Million	CN¥2.49 Billion ≈ $364.42 Million	+3.21pp
2006-12-31	0.08%	CN¥269.00K ≈ $39.36K	CN¥338.04 Million ≈ $49.47 Million	--

pp = percentage points

About Jilin Jian Yisheng Pharmaceutical Co Ltd

SHE:002566 China Biotechnology

Market Cap

$403.41 Million

CN¥2.76 Billion CNY

Market Cap Rank

#13642 Global

#4309 in China

Share Price

CN¥8.33

Change (1 day)

+0.48%

52-Week Range

CN¥7.07 - CN¥9.05

All Time High

CN¥19.38